Humacyte, Inc. (NASDAQ:HUMAW – Get Free Report) saw a large drop in short interest in December. As of December 31st, there was short interest totalling 300 shares, a drop of 75.0% from the December 15th total of 1,200 shares. Based on an average trading volume of 6,800 shares, the short-interest ratio is presently 0.0 days. […]
Humacyte, Inc. (NASDAQ:HUMAW – Get Free Report) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 1,200 shares, an increase of 9.1% from the November 30th total of 1,100 shares. Based on an average daily volume of 6,200 shares, the […]
Humacyte, Inc. (NASDAQ:HUMAW – Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 15,800 shares, a growth of 192.6% from the September 15th total of 5,400 shares. Based on an average daily volume of 4,200 shares, the short-interest ratio is presently 3.8 days. […]
Humacyte, Inc. (NASDAQ:HUMAW – Get Rating) saw a significant increase in short interest in April. As of April 15th, there was short interest totalling 16,600 shares, an increase of 7.1% from the March 31st total of 15,500 shares. Based on an average daily trading volume, of 6,800 shares, the short-interest ratio is currently 2.4 days. […]
Humacyte, Inc. (NASDAQ:HUMAW – Get Rating) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 16,600 shares, a growth of 7.1% from the March 31st total of 15,500 shares. Based on an average daily trading volume, of 6,800 shares, the […]